View all reports
Fate Therapeutics, Inc. (FATE) stock forecast and price target
Find the latest Fate Therapeutics, Inc. fate analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Date Range
investment rating
report type
sector
industry
provider
FATEFate Therapeutics, Inc.4.0000 +0.0400 (+1.01%)
At close: 08:00PM
Recommendation Rating
2.6
Analyst Price Targets (14)
Current?4.00
Average?6.68
Low?3.50
High?12.00
Related Research Reports1-4 of 4 results
| Report Name | Symbols | Sector | Provider | Date | |
|---|---|---|---|---|---|
| KYMR,AEHR,PLAY,JBL,RH,BSTZ,FATE,CTAS | Communication Services,Financial Services,Technology,Healthcare,Industrials,Consumer Cyclical | Argus | Jan 17, 2023 | Upgrade to begin downloading full reports | |
| NTIC,PACB,CSPI,SNSE,TRDA,FATE | Basic Materials,Technology,Healthcare | Argus | Jan 14, 2022 | Upgrade to begin downloading full reports | |
| TPL,RLYB,QSI,G,ANGO,FATE,ASO,HEI | Energy,Technology,Healthcare,Industrials,Consumer Cyclical | Argus | Jan 13, 2022 | Upgrade to begin downloading full reports | |
| RDVT,YAYO,IMXI,STAA,LLY,FATE,LNN | Technology,Healthcare,Industrials | Argus | Jan 13, 2021 | Upgrade to begin downloading full reports |